States sue to halt 23andMe's sale of genetic data without consent

Twenty-seven states and D.C. sued to prevent the sale of 23andMe's personal genetic data without customer consent amid the company's bankruptcy and a proposed sale to Regeneron, citing privacy concerns and the need for informed consent for sensitive health information.